BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 8000255)

  • 1. [Risk of infection in hemotherapy].
    Sibrowski W; Wüllenweber J
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():60-3. PubMed ID: 8000255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk of infection caused by homologous blood transfusion].
    Kühnl P; Löliger C; Laufs R
    Chirurg; 1994 Dec; 65(12):1071-4. PubMed ID: 7851137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of infection transmission by blood components].
    Kubanek B; Cardoso M; Glück D; Koerner K
    Infusionsther Transfusionsmed; 1993 Apr; 20(1-2):54-9. PubMed ID: 8504243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expanded serologic infection testing of autologous blood donors: a report of experiences].
    Zimmermann R; Weisbach V; Wittmann G; Zingsem J; Neidhardt B; Eckstein R
    Beitr Infusionsther Transfusionsmed; 1996; 33():196-200. PubMed ID: 8974693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-transmitted diseases: current problems and challenges.
    Bove JR
    Prog Hematol; 1986; 14():123-47. PubMed ID: 3003795
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benefits and risks of autologous blood donation].
    Penner M; Sibrowski W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():64-8. PubMed ID: 8000256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B--significance for transfusion medicine].
    Jilg W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():20-6. PubMed ID: 8000250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risks of transfusion-transmitted infection: direct estimation and mathematical modelling.
    Kleinman SH; Busch MP
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):631-49. PubMed ID: 11102281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].
    Gürtler L
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():77-9. PubMed ID: 8000260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated hepatitis and AIDS. What is the risk?
    Bove JR
    N Engl J Med; 1987 Jul; 317(4):242-5. PubMed ID: 3110619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of introduction of PCR in blood banks].
    Gürtler L
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):4-6. PubMed ID: 8653016
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular biological screening of viruses important to transfusion medicine].
    Wolff C; Hörnschemeyer D; Skurtopulos M; Petersen N; Beyer J; Seidel K; Mutz A; Kleesiek K
    Beitr Infusionsther Transfusionsmed; 1994; 32():102-9. PubMed ID: 9480064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.